ArticleVeterinary and comparative oncology2026
Comparison of Morbidity Between Sentinel Lymph Node Biopsy and Elective Neck Dissection in Dogs With Head and Neck Malignancies.
Article in Veterinary and comparative oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Elective neck dissection (END) and sentinel lymph node biopsy (SLNB) are suggested for nodal staging of canine head and neck malignancies (HNM). This study aims to compare the morbidity of END to SLNB. Seventy-six client-owned dogs with HNM that underwent END (n = 28) or SLNB (n = 48) in two institutions were retrospectively enrolled. Retrieved variables included data on signalment, lymph centre and lymph nodes, intra- and post-surgical complications (PSC) of lymphadenectomy, and histopathology results. The cumulative incidence of PSC at 30 days was estimated for END and SLNB and compared with Gray's test. The influence of variables on the incidence of complications was evaluated using univariate and multivariate models. No intraoperative complication occurred. The PSC were mostly mild. Seroma was the most frequent. The cumulative incidence of PSC of lymphadenectomy at 30 days was 47.4%, and they were severe in 14% of cases. The incidence of PSC was 25% for SLNB and 85.7% for END, and the difference was statistically significant (p < 0.001). Clinically enlarged nodes (p = 0.03), institution (p = 0.03), increasing number of resected nodes (p < 0.001) and of lymph centres (p < 0.001) predicted a higher incidence of PSC in the univariate model. In the multivariate analysis, only the type of node management (END vs. SLNB) remained significant. Although lymphadenectomy is a well-tolerated procedure in dogs with HNM, END was correlated with a higher risk of PSC compared to SLNB. Stratification of dogs by the risk of multiple nodal metastases is warranted to identify those who may still benefit from END despite a higher PSC risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.